Suchergebnisse - "PECORA ANDREW"

PubPharm (185)

1

Translational Aspects of Epithelioid Sarcoma : Current Consensus

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Grünewald, T. | Postel-Vinay, S. | Nakayama, R. | +23

2

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942) : a randomised, phase 2b study

enthalten in: Lancet (London, England) | 2024

von Weber, J. | Carlino, M. | Khattak, A. | +31

3

CLINICAL OUTCOME TRACKING AND ANALYSIS EMPLOYING PROVISIONAL/REFINED NODAL ADDRESSES RELEVANT TO TREATMENT/PROGNOSIS-RELATED OUTCOME AND RISK ASSESSMENT

enthalten in: Europäisches Patentamt | 2023

von PECORA ANDREW L | NORDEN ANDREW

4

CLINICAL OUTCOME TRACKING AND ANALYSIS

enthalten in: Europäisches Patentamt | 2023

von PECORA ANDREW L

5

The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma : A real-world, multicenter, retrospective study

enthalten in: Cancer | 2023

von Lev-Ari, S. | Serzan, M. | Wu, T. | +17

6

Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors

enthalten in: Heliyon | 2023

von Albitar, M. | Zhang, H. | Charifa, A. | +9

7

Homologous Recombination Abnormalities Associated With BRCA1/2 Mutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing Data

enthalten in: Breast cancer : basic and clinical research | 2023

von Albitar, M. | Zhang, H. | Pecora, A. | +8

8

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma : The DREAMseq Trial-ECOG-ACRIN EA6134

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Atkins, M. | Lee, S. | Chmielowski, B. | +33

CommentIn: Nat Rev Clin Oncol. 2023 Jan;20(1):1. - PMID 36352267

9

HUMAN PLACENTAL HEMATOPOIETIC STEM CELL DERIVED NATURAL KILLER CELLS IN ACUTE MYELOID LEUKEMIA (AML) REMISSION WITH MINIMAL RESIDUAL DISEASE (MRD) OR RELAPSED/REFRACTORY AML

enthalten in: Europäisches Patentamt | 2023

von HARIRI ROBERT J | PECORA ANDREW L | VAN DER TOUW WILLIAM | +2

10

Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial Intelligence

enthalten in: The American journal of pathology | 2023

von Zhang, H. | Qureshi, M. | Wahid, M. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]